BKBethany R. Kondiles

Bethany R. Kondiles

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bethany R. Kondiles has a total of 50 co-authors. Here are the top co-authors by number of shared publications:

  • Wolfram Tetzlaff

    International Collaboration on Repair Discoveries (ICORD), University of British Columbia, Vancouver, BC, Canada

    3 shared publications
  • Bobo Tong

    International Collaboration on Repair Discoveries (ICORD), University of British Columbia, Vancouver, BC, Canada

    2 shared publications
  • Catherine R. Jutzeler

    Department of Health Sciences and Technology, ETH Zürich, Zürich, Switzerland

    2 shared publications
  • Jaimie J. Lee

    Faculty of Medicine, University of British Columbia

    2 shared publications
  • John L. K. Kramer

    International Collaboration on Repair Discoveries (ICORD), University of British Columbia, Vancouver, BC, Canada

    2 shared publications
  • Louis P. Lukas

    Department of Health Sciences and Technology (D-HEST), ETH Zurich, Universitätstrasse 2, 8092 Zürich, Switzerland; Schulthess Klinik, Lengghalde 2, 8008 Zürich, Switzerland; SIB Swiss Institute of Bioinformatics, Switzerland

    2 shared publications

Latest Publications

  • Open Access

    Author Correction: Impact of commonly administered drugs on the progression of spinal cord injury: a systematic review

    by Lucie Bourguignon, Louis P. Lukas, Bethany R. Kondiles, Bobo Tong, Jaimie J. Lee, Tomás Gomes, Wolfram Tetzlaff, John L. K. Kramer, Matthias Walter, Catherine R. Jutzeler

  • Open Access

    Improving recovery from traumatic spinal cord injury: Targeting remyelination versus white matter remodeling

    by Bethany R. Kondiles, Wolfram Tetzlaff

    An abstract is unavailable. This article is available as a PDF only.

  • Age and Sex Affect the Chronic Trajectory of Plasma Neurofilament Light and Glial Fibrillary Acidic Protein Levels in a Murine Thoracic Contusion Spinal Cord Injury Model

    by Bethany R. Kondiles, Jianjia Fan, Wai Hang Cheng, Cheryl Wellington, Wolfram Tetzlaff

    Background: Mouse models of traumatic spinal cord injury (SCI) are used to understand pathophysiology and test potential interventions. Experimental injury parameters, deficits on functional tasks, and histology are used to assess severity and recovery. Blood biomarkers may be a promising additional metric to assess severity and detect efficacy of interventions, but they have not been examined previously in mouse spinal cord injury (SCI). Objectives: To examine blood biomarkers in mouse SCI. Methods: We measured plasma levels of neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) longitudinally following a thoracic contusion SCI in adolescent (3 month old) and aged (18 month old) male and female C57Bl6/J mice. Biomarkers were also assessed in comparably aged uninjured animals. Results: Three-month-old animals exhibited elevated plasma NfL and GFAP 1 month after injury. NfL levels decreased from 1 to 2 months post injury but remained elevated from baseline, while GFAP levels remained high. Adolescent males exhibited higher NfL levels than females post injury. In aged animals, NfL was comparably elevated at 1 and 2 months post injury. In aged females, GFAP was elevated at 1 and 2 months after injury, while levels in males did not increase from baseline until 2 months after injury. Values from uninjured animals show plasma NfL and GFAP increase with age in absence of injury. Conclusion: In a mouse SCI model, plasma NfL and GFAP are elevated chronically after injury. Sex and age at injury may affect biomarker trajectories, which may indicate underlying pathology relevant to treatment and recovery. Establishing the trajectory of NfL and GFAP after experimental injury may help to standardize injury paradigms, assess recovery, and detect efficacy of interventions.


  • Open Access

    Lessons Learned and Recommendations from a SCOPE Spinal Cord Injury Neurorestorative Clinical Trials Update

    by Bethany R. Kondiles, Sabhya Rana, David Weiner, Armin Blesch, James St. John, Cornelia Haag-Molkenteller, Patrick Freund, James Guest, Daniel D. Mikol, Susan Harkema, et al.

    The Spinal Cord Outcomes Partnership Endeavors presented a clinical trials update (CTU) in collaboration with the International Spinal Research Trust as a precourse to their annual meeting. Selected trials adhered to a priori considerations, prioritizing novelty and a focus on neurorestorative approaches. The sessions featured 13 speakers, covering 4 in-preparation, 4 in-progress, and 4 recently completed trials. In addition to in-person attendance, individuals worldwide viewed a live stream of the presentations. Approximately 1600 participants, comprising clinicians, researchers, industry stakeholders, foundations, and individuals with lived experiences, engaged in the CTU through both in-person and virtual channels. Presentations represented a variety of approaches, including drug, biological, and device-based therapeutics. This summary provides high-level summaries of the trials presented and the resulting discussions including lessons learned. Rather than recapitulating published data, the presentations and discussions emphasized the novelty and strengths of each trial, practical aspects of translation, and lessons learned. Throughout the day, several discussion themes surfaced. These included reflections on the suitability of outcome measures and the distinction between statistically or clinically meaningful effects and meaningful changes in quality of life. Additional topics included novel trial designs, selection of inclusion criteria, recognizing the indispensable role of rehabilitation, tailoring approaches to individual needs, the importance of integrating lived experience, and emphasizing the importance of establishing robust pre-clinical data packages before venturing into clinical translation. Importantly, strategic directives are summarized to address these challenges, focusing resources and efforts to steer forthcoming trials effectively.


  • Open Access

    Impact of commonly administered drugs on the progression of spinal cord injury: a systematic review

    by Lucie Bourguignon, Louis P. Lukas, Bethany R. Kondiles, Bobo Tong, Jaimie J. Lee, Tomás Gomes, Wolfram Tetzlaff, John L. K. Kramer, Matthias Walter, Catherine R. Jutzeler

    Background: Complications arising from acute traumatic spinal cord injury (SCI) are routinely managed by various pharmacological interventions. Despite decades of clinical application, the potential impact on neurological recovery has been largely overlooked. This study aims to highlight commonly administered drugs with potential disease-modifying effects. Methods: This systematic literature review included studies referenced in PubMed, Scopus and Web of Science from inception to March 31st, 2021, which assess disease-modifying properties on neurological and/or functional recovery of drugs routinely administered following spinal cord injury. Drug effects were classified as positive, negative, mixed, no effect, or not (statistically) reported. Risk of bias was assessed separately for animal, randomized clinical trials, and observational human studies. Results: We analyzed 394 studies conducting 486 experiments that evaluated 144 unique or combinations of drugs. 195 of the 464 experiments conducted on animals (42%) and one study in humans demonstrate positive disease-modifying properties on neurological and/or functional outcomes. Methylprednisolone, melatonin, estradiol, and atorvastatin are the most common drugs associated with positive effects. Two studies on morphine and ethanol report negative effects on recovery. Conclusion: Despite a large heterogeneity observed in study protocols, research from bed to bench and back to bedside provides an alternative approach to identify new candidate drugs in the context of SCI. Future research in human populations is warranted to determine if introducing drugs like melatonin, estradiol, or atorvastatin would contribute to enhancing neurological outcomes after acute SCI.


  • Open Access

    Compensatory changes after spinal cord injury in a remyelination deficient mouse model

    by S. B. Manesh, B. R. Kondiles, S. Wheeler, J. Liu, L. Zhang, C. Chernoff, G. J. Duncan, M. S. Ramer, W. Tetzlaff

    The development of therapeutic strategies to reduce impairments following spinal cord injury (SCI) motivates an active area of research, because there are no effective therapies. One strategy is to address injury‐induced demyelination of spared axons by promoting endogenous or exogenous remyelination. However, previously, we showed that new myelin was not necessary to regain hindlimb stepping following moderate thoracic spinal cord contusion in 3‐month‐old mice. The present analysis investigated two potential mechanisms by which animals can re‐establish locomotion in the absence of remyelination: compensation through intact white matter and conduction through spared axons. We induced a severe contusion injury to reduce the spared white matter rim in the remyelination deficient model, with no differences in recovery between remyelination deficient animals and injured littermate controls. We investigated the nodal properties of the axons at the lesion and found that in the remyelination deficient model, axons express the Nav1.2 voltage‐gated sodium channel, a sub‐type not typically expressed at mature nodes of Ranvier. In a moderate contusion injury, conduction velocities through the lesions of remyelination deficient animals were similar to those in animals with the capacity to remyelinate after injury. Detailed gait analysis and kinematics reveal subtle differences between remyelination deficient animals and remyelination competent controls, but no worse deficits. It is possible that upregulation of Nav1.2 channels may contribute to establishing conduction through the lesion. This conduction could contribute to compensation and regained motor function in mouse models of SCI. Such compensatory mechanism may have implications for interpreting efficacy results for remyelinating interventions in mice and the development of therapies for improving recovery following SCI. image


  • Open Access

    Cortical stimulation leads to shortened myelin sheaths and increased axonal branching in spared axons after cervical spinal cord injury

    by B. R. Kondiles, R. L. Murphy, A. J. Widman, S. I. Perlmutter, P. J. Horner

    Neural activity and learning lead to myelin sheath plasticity in the intact central nervous system (CNS), but this plasticity has not been well‐studied after CNS injury. In the context of spinal cord injury (SCI), demyelination occurs at the lesion site and natural remyelination of surviving axons can take months. To determine if neural activity modulates myelin and axon plasticity in the injured, adult CNS, we electrically stimulated the contralesional motor cortex at 10 Hz to drive neural activity in the corticospinal tract of rats with sub‐chronic spinal contusion injuries. We quantified myelin and axonal characteristics by tracing corticospinal axons rostral to and at the lesion epicenter and identifying nodes of Ranvier by immunohistochemistry. Three weeks of daily stimulation induced very short myelin sheaths, axon branching, and thinner axons outside of the lesion zone, where remodeling has not previously been reported. Surprisingly, remodeling was particularly robust rostral to the injury which suggests that electrical stimulation can promote white matter plasticity even in areas not directly demyelinated by the contusion. Stimulation did not alter myelin or axons at the lesion site, which suggests that neuronal activity does not contribute to myelin remodeling near the injury in the sub‐chronic period. These data are the first to demonstrate wide‐scale remodeling of nodal and myelin structures of a mature, long‐tract motor pathway in response to electrical stimulation. This finding suggests that neuromodulation promotes white matter plasticity in intact regions of pathways after injury and raises intriguing questions regarding the interplay between axonal and myelin plasticity.


  • Open Access

    Transcriptome of rat subcortical white matter and spinal cord after spinal injury and cortical stimulation

    by Bethany R. Kondiles, Haichao Wei, Lesley S. Chaboub, Philip J. Horner, Jia Qian Wu, Steve I. Perlmutter

    Spinal cord injury disrupts ascending and descending neural signals causing sensory and motor dysfunction. Neuromodulation with electrical stimulation is used in both clinical and research settings to induce neural plasticity and improve functional recovery following spinal trauma. However, the mechanisms by which electrical stimulation affects recovery remain unclear. In this study we examined the effects of cortical electrical stimulation following injury on transcription at several levels of the central nervous system. We performed a unilateral, incomplete cervical spinal contusion injury in rats and delivered stimulation for one week to the contralesional motor cortex to activate the corticospinal tract and other pathways. RNA was purified from bilateral subcortical white matter and 3 levels of the spinal cord. Here we provide the complete data set in the hope that it will be useful for researchers studying electrical stimulation as a therapy to improve recovery from the deficits associated with spinal cord injury.


  • Cover Image

    by Bethany R. Kondiles, Philip J. Horner